Association between gene polymorphism of manganese superoxide dismutase and prostate cancer risk

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 3, 2013, Pages 213-218

  Eken, Ayşe ^a,b   Erdem, Onur ^b   Arsova Sarafinovska, Zorica ^c   Akay, Cemal ^b   Sayal, Ahmet ^b   Matevska, Nadica ^d   Suturkova, Ljubica ^d   Erten, Koray ^b   Özgök, Yaşar ^b   Dimovski, Aleksandar ^d   Aydin, Ahmet ^b,e  

^a ERCIYES UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c Institute of Public Health of the Republic of Macedonia   (Macedonia)

^d SS Cyril and Methodius University Faculty of Pharmacy   (Macedonia)

^e YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Antioxidant Effect; Genetic Polymorphism; Manganese Superoxide Dismutase; Prostatic Cancer; Reactive Oxygen Species

Indexed keywords

MANGANESE; SUPEROXIDE DISMUTASE;

ADULT; ALLELE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RISK; CLINICAL ARTICLE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; SUPEROXIDE DISMUTASE; TURKEY;

EID: 84875056224     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21472     Document Type: Article

References (36)

1. Liwei L, Chunyu L, Ruifa H. Association between manganese superoxide dismutase gene polymorphism and risk of prostate cancer: a meta-analysis. Urology 2009;74:884-888.
2. Ergen HA, Narter F, Timirci O, Isbir T. Effects of manganese superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study. Anticancer Res 2007;27:1227-1230.
3. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84-93.
4. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002;33:337-349.
5. Kucukgergin C, Sanli O, Tefik T, Aydin M, Ozcan F, Seckin Ş. Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism. Mol Biol Rep 2012;39(1):193-198.
6. Bica CG, Da Cruz IB, Da Silva LL, Toscani NV, Zettler CG, Graudenz MS. Association of manganese superoxide dismutase gene polymorphism (Ala-9Val) and breast cancer in males and females. J Bras Patol Med Lab 2007;43:219-225.
7. Shimoda-Matsubayashi S, Mtasumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996;226:561-565.
8. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, Zheng W. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai breast cancer study. Breast Cancer Res 2004;6:647-655.
9. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, Ma J. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005;65:2498-2504.
10. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K, Erdman JW, Jr, Giovannucci E. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008;29:2335-2340.
11. Bandy B, Davison, AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 1990;8:523-539.
12. Nock NL, Cicek MS, Li L, Liu X, Rybicki BA, Moreira A, Plummer SJ, Casey G, Witte JS. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 2006;27:1842-1848.
13. Adaramoye OA, Akinloye O, Olatunji IK. Trace elements and vitamin E status in Nigerian patients with prostate cancer. Afr Health Sci 2010;10(1):2-8.
14. Yilmaz HH, Yazihan N, Tunca D, Sevinç A, Olcayto EÖ, Özgül N, Tuncer M. Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol 2010;41(1):10-16.
15. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62 (Suppl 6A):3-12.
16. Klein EA, Casey G, Silverman R. Genetic susceptibility and oxidative stress in prostate cancer: Integrated model with implications for prevention. Urology 2006;68:1145-1151.
17. Valko M, Leibfritz D, Moncol J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
18. Valko M, Rhodes CJ, Moncol J. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
19. Millikan RC, Player J, Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse C-KJ, Keku T. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in popluation based case-control study of African Americans and Whites. Breast Cancer Res 2004;6:264-274.
20. Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, Wang X, Shen H, Hu Z. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk-A meta analysis. Eur J Cancer 2009;45:2874-2881.
21. Ambrosone C, Freudenheim J, Thompson P, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG. Manganese superoxide dismutase (MnSOD) genetic polymorphism, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-606.
22. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Uusitupa M, Hirvonen A. Association between manganese superoxide dismutase (MnSOD) genetic polymorphism and breast cancer risk. Carcinogenesis 2001;22:827-829.
23. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:989-996.
24. Kocabaş NA, Sardaş S, Cholerton S, Daly AK, Elhan AH, Karakaya AE. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochem Funct 2005;23:73-76.
25. Woodson K, Tangrea J, Lehman T, Modali R, Taylor KM, Synder K, Taylor PR, Virtamo J, Albanes D. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control 2003;14:513-518.
26. Kang D, Lee KM, Park SK, Berndt SI, Peters U, Rading D, Chatterjee N, Welch R, Chanock S, Huang W-Y, Hayes RB. Functional variant of manganese superoxide dismutase (SOD2V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007;16:1581-1586.
27. Wang L, Miller D, Sai Y, Liu G, Su L, Wain JC, Lynch TJ, Christiani DC. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst 2001;93:1818-1821.
28. Hung R, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S. Genetic polymorphisms of MPO, COMP, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004;25:973-978.
29. Bostwick DG. Grading prostate cancer. Am J Clin Pathol 1994;102:38-S56.
30. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of pheripheral blood: analysis of beta-like globin genes. Hemoglobin 1982;6:27-36.
31. th November 2011.
32. Choi JY, Neuhouser ML, Barnett M. Hudson M, Kristal AR, Thornquist M, King IB, Goodman GE, Ambrosone CB. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007;16:1115-1120.
33. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, Ma J. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96(9):696-703.
34. Arsova-Sarafinovska Z, Matevska N, Petrovski D, Banev S, Dzikova S, Georgiev V, Sikole A, Sayal A, Aydin A, Suturkova L, Dimovski AJ. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem Funct 2008;26:771-777.
35. Iguchi T, Sugita S, Wang CY, Newman NB, Nakatani T, Haas GP. MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status. In vivo 2009;23:7-12.
36. Arsova-Sarafinovska Z, Matevska N, Eken A, Petrovski D, Banev S, Dzikova S, Georgiev V, Sikole A, Erdem O, Sayal A, Aydin A, Dimovski AJ. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol 2009;41:63-70.